期刊文献+

CADM1过表达对人胃癌MKN-45细胞增殖和侵袭的影响及其分子机制 被引量:10

Effects of CADM1 overexpression on proliferation and invasion of human gastric carcinoma cell line MKN-45
暂未订购
导出
摘要 目的:研究细胞黏附分子1(cell adhesion molecule 1,CADM1)过表达对人胃癌MKN-45细胞增殖和侵袭的影响并探讨其可能的分子机制。方法:采用Western blotting检测3株胃癌细胞系中CADM1蛋白的表达。构建pcDNA-CADM1真核表达载体,并将其转染MKN-45细胞,采用G418筛选稳定表达CADM1的细胞株,利用Western blotting鉴定所筛选的稳定细胞株。采用CCK-8试剂和Boyden小室分析过表达CADM1对MKN-45细胞增殖和侵袭的影响。利用Western blotting检测细胞增殖和侵袭相关蛋白表达。结果:MKN-45细胞中CADM1蛋白的相对表达水平显著低于MKN-28和SGC-7901细胞(P<0.05)。此外,成功构建pcDNA-CADM1真核表达载体,并获得稳定过表达CADM1的MKN-45细胞株。CCK-8结果显示,与未处理组和pcDNA3.1组相比,pcDNA-CADM1组中MKN-45细胞的增殖明显受到抑制(P<0.05)。Boyden小室体外侵袭实验结果显示,与未处理组(101.53±6.89)和pcDNA3.1组(98.77±7.03)相比,pcDNA-CADM1组中MKN-45细胞穿膜的细胞数(52.35±3.89)显著减少(P<0.05)。Western blotting结果显示,与未处理组和pcDNA3.1组相比,pcDNA-CADM1组中p21蛋白表达显著上调,而MMP-2和MMP-9表达显著下调(P<0.05)。结论:CADM1过表达能明显抑制胃癌细胞的增殖和侵袭能力,因而CADM1有望成为胃癌治疗的新靶点。 AIM: To investigate the effects of CADM1 overexpression on proliferation and invasion of human gastric carcinoma cell line MKN -45. METHODS: The protein levels of CADM1 in 3 human gastric carcinoma cell lines were detected by Western blotting. Eukaryotic expression vector pcDNA - CADM1 was constructed and transfected into MKN -45 cells. The MKN -45 cells stably expressing CADM1 were selected by G418 and identified by Western blotting. Furthermore, CCK - 8 assay and Boyden chamber were used to analyze the effects of CADM1 overexpression on the prolife- ration and invasion of gastric carcinoma cells. Western blotting was also utilized to detect the levels of cell proliferation - and invasion- related proteins. RESULTS: Relative level of CADM1 protein in MKN -45 cells was significantly lower than that in MKN - 28 ceils and SGC - 7901 cells. Additionally, eukaryotic expression vector pcDNA - CADM1 was suc- cessfully constructed and MKN - 45 cells stably expressing CADM1 were obtained. Compared with non - treatment and pcDNA3.1 groups, the proliferation of MKN -45 cells was obviously inhibited in pcDNA - CADM1 group. The result of Boyden chamber showed that the migrated cell numbers in pcDNA - CADM1 group (52.35±3.89) were significantly lower than that in untreated group (101.53±6.89) and pcDNA3.1 group (98.77±7.03). Compared with non -treatment and pcDNA3.1 groups, the protein level of p21 was significantly up -regulated and protein expression of MMP- 2 and MMP-9 was obviously down -regulated. CONCLUSION: Overexpression of CADM1 may markedly inhibit cell proliferation and reduce invasion ability, and thus may be a novel target for treating gastric carcinoma.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第12期2283-2287,共5页 Chinese Journal of Pathophysiology
基金 河南省教育厅科技攻关项目(No.2009B320008) 河南省卫生厅科技攻关课题(No.200804055)
关键词 胃肿瘤 细胞黏附分子1 细胞增殖 细胞侵袭 Stomach neoplasms Cell adhesion molecule 1 Cell proliferation Cell invasion
  • 相关文献

参考文献23

  • 1Murakami Y, Nobukuni T, Tamura K, et al. Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11 q [ J ]. Proc Nail Acad Sci U S A, 1998, 95(14) : 8153 -8158.
  • 2Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLCI is a tumor - suppressor gene in human non - small - cell lung cancer[J]. Nat Genet, 2001, 27(4) : 427 -430.
  • 3Yamada D, Yoshida M, Williams YN, et al. Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule[J]. Mol Cell Biol, 2006, 26(9) : 3610 - 3624.
  • 4Shingai T, Ikeda W, Kakunaga S, et al. Implications of nectin - like molecule - 2/IGSF4/RA175/SgIGSF! TSLC1/SynCAM1 in cell -cell adhesion and transmem- brane protein localization in epithelial cells [ J ]. J Biol Chem, 2003, 278 (37) : 35421 - 35427.
  • 5Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcino- ma[J]. Cancer Res, 2003, 63(19) : 6320-6326.
  • 6Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical ne- oplasia[ J ]. J Natl Cancer Inst, 2004, 96 (4) : 294 - 305.
  • 7He G, Lei W, Wang S, et al. Overexpression of tumor suppressor TSLC1 by a survivin- regulated oncolytie ade- novirus significantly inhibits hepatoceUular carcinoma growth [ J ]. J Cancer Res Clin Oncol, 2012, 138 (4) : 657 - 670.
  • 8Yang G, He W, Cai M, et al. Loss/Down -regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma[ J]. Int J Gynecol Cancer, 2011, 21 (3) : 486 - 493.
  • 9Heller G, Geradts J, Ziegler B, et al. Downregulation of TSLC1 and DAL - 1 expression occurs frequently in breast cancer[J]. Breast Cancer Res Treat, 2007, 103(3) : 283 - 291.
  • 10Busam RD, Thorsell AG, Flores A, et al. Structural ba- sis of tumor suppressor in lung cancer 1 (TSLC1) binding to differentially expressed in adenocarcinoma of the lung (DAL-1/4. 1B)[J]. J Biol Chem, 2011, 286(6): 4511 -4516.

同被引文献121

  • 1欧凯,杨林.胃癌免疫治疗机制及临床应用的研究进展[J].中国肿瘤,2020,0(2):125-133. 被引量:19
  • 2张杰,申兵冰,何俊,文富强,付平,黄颂敏.槲皮素对系膜细胞增殖、凋亡及细胞周期影响的初步研究[J].西部医学,2006,18(2):131-133. 被引量:2
  • 3Lyra-Gonzalez I, Flores-Fong LE, Gonzdlez-Garcia I,, et al. Adenoviral gene therapy in hepatocellular carcinoma: a review [ J ]. Hepatol Int, 2013, 7 ( 1 ) :48-58.
  • 4Hoashi T, Sato S, Yamaguchi Y, et al. Glycoprotein non- metastatic melanoma protein b, a melanocytic eell mar- ker, is a melanosome-specific and proteolytically released protein[J]. FASEB J, 2010, 24(5) :1616-1629.
  • 5Tomihari M, Hwang SH, Chung JS, et al. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion[J]. Exp Dermatol, 2009, 18(7) :586-595.
  • 6Choi ET, Engel L, Callow AD, et al. Inhibition of neoint- imal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA [ J ]. J Vasc Surg, 1994, 19(1) :125-134.
  • 7Tsujimoto M, Aozasa K, Nakajima Y, et al. Hepatocellu- lar carcinoma with sarcomatous proliferation showing an unusual and wide-spread metastasis [ J ]. Acta Pathol Jpn, 1984, 34(4) :839-845.
  • 8Zhou L, Liu F, Li Y, et al. Gpnmb/osteoactivin, an at- tractive target in cancer immunotherapy [ J ]. Neoplasma, 2012, 59(1) :1-5.
  • 9Desgrosellier JS, Cheresh DA. Integrins in cancer: biolog- ical implications and therapeutic opportunities [ J ]. Nat Rev Cancer, 2010, 10(1) :9-22.
  • 10Raymond K, Faraldo MM, Deugnier MA, et al. Integrins in mammary development [ J ]. Semin Cell Dev Biol, 2012, 23(5) :599-605.

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部